We are live on
!
Find out more
AVAX
Atlas Venture Associates XI Portfolio holdings
AUM
$631M
This Fund
S&P 500
This Quarter
Est. Return
+77.83%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$631M
AUM Growth
–
Cap. Flow
+$474M
Cap. Flow
% of AUM
75.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIRY
Firy Inc
FIRY
|
+$346M |
| 2 |
Intellia Therapeutics
NTLA
|
+$58.7M |
| 3 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
+$25.6M |
| 4 |
Spero Therapeutics
SPRO
|
+$21.5M |
| 5 |
Cogent Biosciences
COGT
|
+$10.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 74.99% |
| 2 | Healthcare | 25.01% |
Similar funds
DK
IVA
WEC
DBC
PJB
HCM
TAM
PSSGI
Atlas Venture Associates XI's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Atlas Venture Associates XI, which disclosed 7 positions worth $631M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Firy Inc: 1,164,220 shares worth $466M.
By sector, the portfolio is most concentrated in Communication Services at 75% of assets, followed by Healthcare.
- Atlas Venture Associates XI's largest Q4 2020 buy was Firy Inc: 1,164,220 shares worth $466M.
- Atlas Venture Associates XI's ten largest holdings make up 100% of its $631M portfolio in Q4 2020.
- Atlas Venture Associates XI disclosed 7 positions in Q4 2020, its first 13F filing on record.
Based on Atlas Venture Associates XI's 13F filing for Q4 2020, filed 1 Feb 2021.